We are live on ! Find out more
CPHI icon

China Pharma Holdings

7 hedge funds and large institutions have $1.18M invested in China Pharma Holdings in 2013 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

31% more capital invested

Capital invested by funds: $902K → $1.18M (+$279K)

0% more funds holding in top 10

Funds holding in top 10: 22 (0)

0% less ownership

Funds ownership: 0.02%0.02% (-0%)

22% less funds holding

Funds holding: 97 (-2)

67% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 3

67% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 3

Holders
7
Holders Change
-2
Holders Change %
-22.22%
% of All Funds
0.23%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.06%
New
1
Increased
1
Reduced
3
Closed
3
Calls
Puts
Net Calls
Net Calls Change

CPHI Hedge Fund Activity: Q3 2013 in Review

7 of the 3,084 institutional investors tracked by Wall St. Rank reported a position in China Pharma Holdings (CPHI) for Q3 2013, worth a combined $1.18M — up 31% from $902K a quarter earlier.

Sellers outnumbered buyers: 3 funds closed out of CPHI and 1 opened new positions — a net loss of 2 holders — while 3 trimmed existing stakes and 1 added.

The largest buyer was First Wilshire Securities Management, adding an estimated $6.47K. The largest seller was Straus Capital Management, cutting an estimated $20.6K.

  • 7 institutional investors held China Pharma Holdings (CPHI) as of Q3 2013, down from 9 in Q2 2013.
  • Funds reported $1.18M of China Pharma Holdings stock for Q3 2013, up 31% quarter-over-quarter.
  • 1 fund opened new China Pharma Holdings positions in Q3 2013 and 3 closed out, a net change of -2 holders.
  • The largest China Pharma Holdings buyer in Q3 2013 was First Wilshire Securities Management, an estimated $6.47K added.
  • The largest China Pharma Holdings seller in Q3 2013 was Straus Capital Management, an estimated $20.6K sold.

Based on aggregated 13F filings for Q3 2013.